CVS - CIK 0000064803
CVS HEALTH Corp trades as CVS and has a market capitalization of $124.91 B, making it the #120 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $402.07B, up 7.8% from the prior year and net income of $1.77B. This page tracks CVS HEALTH Corp through 1,017 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years CVS HEALTH Corp's revenue grew from $177.53B to $402.07B, a compound annual growth rate of 9.5%. Net profit margin compressed from 3.0% to 0.4% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider sale notice | 144 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Major company event | 8-K | 2026-05-18 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
The largest companies sharing CVS HEALTH Corp's SEC industry classification (retail-drug stores and proprietary stores).
CVS HEALTH Corp (CVS) has a market capitalization of $124.91 B as of 2026-06-10, ranking #120 among US-listed companies.
CVS HEALTH Corp reported revenue of $402.07B for fiscal year 2025, an increase of 7.8% year over year.
Yes. CVS HEALTH Corp reported net income of $1.77B in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.